Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet

PLoS One. 2020 Aug 12;15(8):e0234750. doi: 10.1371/journal.pone.0234750. eCollection 2020.

Abstract

The incidence of nonalcoholic steatohepatitis (NASH) is increasing worldwide, including in Asian countries. We reported that the hepatic expression of bile salt export pump (BSEP) was downregulated in patients with NASH, suggesting that BSEP is involved in the pathogenesis of NASH. To identify the underlying mechanism, we analyzed Bsep heterozygous knock-out (Bsep+/- mice) and wild-type (WT) C57BL/6J mice fed a high-fat diet (HFD) (32.0% animal fat) or normal diet. We examined histological changes, levels of hepatic lipids and hepatic bile acids, and expression of genes related to bile acid and cholesterol metabolism. HFD-fed Bsep+/- mice exhibited milder hepatic steatosis and less weight gain, compared to HFD-fed WT mice. The concentrations of total bile acid, triglycerides, and cholesterols were reduced in the liver of HFD-fed Bsep+/- mice. Regarding hepatic bile acid metabolism, the expression levels of Farnesoid X receptor (Fxr) and Multidrug resistance-associated protein 2 were significantly upregulated in HFD-fed Bsep+/- mice, compared to HFD-fed WT mice. Furthermore, several alterations were observed in upstream cholesterol metabolism in the liver. The expression levels of bile acid metabolism-related genes were also altered in the intestine of HFD-fed Bsep+/- mice. In conclusion, HFD-fed Bsep+/- mice exhibited significant alterations of the expression levels of genes related to bile acid and lipid metabolism in both the liver and ileum, resulting in alleviated steatosis and less weight gain. These results suggest the importance of BSEP for maintenance of bile acid and cholesterol metabolism. Further investigations of the involvement of BSEP in the pathogenesis of NASH will provide greater insight and facilitate the development of novel therapeutic modalities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 11 / deficiency*
  • ATP Binding Cassette Transporter, Subfamily B, Member 11 / genetics
  • Animals
  • Bile Acids and Salts / metabolism
  • Cholesterol / metabolism
  • Diet, High-Fat / adverse effects*
  • Disease Models, Animal
  • Heterozygote
  • Ileum / metabolism
  • Lipid Metabolism
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 11
  • Abcb11 protein, mouse
  • Bile Acids and Salts
  • Cholesterol

Grants and funding

This independent research is supported by AMED under Grant Number JP19fk0210040 and JP20fk0210040 (to KK), JSPS KAKENHI Grant Number JP17K15929 and JP20K17014 (to KO), and the Gilead Sciences Research Scholars Program in Liver Disease‐Japan (to KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.